Abstract 3255: Investigate immune regulation and therapeutic efficacy via regorafenib combined with PD-L1 inhibitor in glioblastoma
Authors: Dai-Cheng Dong, Yu-Chiang Liu
Published: 2023-04-04
DOI:
10.1158/1538-7445.am2023-3255
Source:
Full article
Abstract
Abstract